US FDA approves Ipsen's SohonosTM (palovarotene) capsules,
Breakthrough treatment reduces new, abnormal bone formation in soft and connective tissues, in people living with ultra-rare bone disease, fibrodysplasia...
Source: globenewswire.com
Page 2 - Bone Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bone Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bone Disorders Today - Breaking & Trending Today
US FDA approves Ipsen's SohonosTM (palovarotene) capsules, the first and only treatment for people with fibrodysplasia ossificans progressiva
Breakthrough treatment reduces new, abnormal bone formation in soft and connective tissues, in people living with ultra-rare bone disease, fibrodysplasia ossificans progressiva FOP impacts about 400... -Today at 03:33 pm- MarketScreener
Source: marketscreener.com
Chronic Kidney Disease Mineral and Bone Disorders (CKD-MBD) Market
Chronic Kidney Disease Mineral and Bone Disorders (CKD-MBD) Market
Source: pr-inside.com
Histone Deacetylase 2 (Transcriptional Regulator Homolog
Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3. 5. ...
Source: globenewswire.com
Expert reviews discuss key topics in bone disorders and chronic kidney disease
E-Mail Metabolic bone disease is a common complication of chronic kidney disease (CKD) and involves a broad spectrum of disorders of mineral metabolism that result in both skeletal and extra-skeletal consequences. A new special issue of Calcified Tissue International brings together a comprehensive series of state-of-the-art reviews which discuss key issues in CKD and mineral and bone disorders, known as CKD-MBD. Authored by a multidisciplinary group of leading international experts, the wide-ranging reviews aim to improve the understanding and management of CKD-MBD, and advance interdisc...
Source: eurekalert.org